secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001493152-24-038583
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics enters ATM equity offering agreement with H.C. Wainwright for up to $1.14M
--------------------------------------------------------------------------------

- Entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC to sell common stock shares from time to time.
- Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $1,143,121.
- Commission to Wainwright at 3.0% of gross proceeds; Company to reimburse expenses up to $100,000 plus due diligence fees.
- Offering terminates upon sale of $1.14M or termination by either party; Company not obligated to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/0001493152-24-038583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer